Healthcare provider profile · identity verified

David Tomaselli

Family Practice · NATRONA HEIGHTS, PA · NPI 1770559072

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	896	260
Lisinopril	Lisinopril	572	166
Levothyroxine Sodium	Levothyroxine Sodium	566	139
Losartan Potassium	Losartan Potassium	463	129
Amlodipine Besylate	Amlodipine Besylate	451	133
Metoprolol Succinate	Metoprolol Succinate	397	113
Omeprazole	Omeprazole	369	96
Simvastatin	Simvastatin	333	96
Hydrochlorothiazide	Hydrochlorothiazide	285	87
Tamsulosin Hcl	Tamsulosin Hcl	264	75
Metformin Hcl	Metformin Hcl	249	70
Metoprolol Tartrate	Metoprolol Tartrate	248	78
Pantoprazole Sodium	Pantoprazole Sodium	238	85
Allopurinol	Allopurinol	234	50
Furosemide	Furosemide	233	89
Gabapentin	Gabapentin	224	65
Sertraline Hcl	Sertraline Hcl	197	59
Montelukast Sodium	Montelukast Sodium	189	51
Eliquis	Apixaban	184	41
Famotidine	Famotidine	167	54
Clopidogrel	Clopidogrel Bisulfate	164	31
Atenolol	Atenolol	158	33
Fluticasone Propionate	Fluticasone Propionate	158	51
Meloxicam	Meloxicam	134	45
Trazodone Hcl	Trazodone Hcl	130	36
Pravastatin Sodium	Pravastatin Sodium	129	42
Lorazepam	Lorazepam	126	28
Potassium Chloride	Potassium Chloride	126	43
Warfarin Sodium	Warfarin Sodium	126	20
Glipizide Er	Glipizide	122	39
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	118	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	116	23
Albuterol Sulfate Hfa	Albuterol Sulfate	112	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	23
Tramadol Hcl	Tramadol Hcl	110	34
Hydralazine Hcl	Hydralazine Hcl	106	31
Jardiance	Empagliflozin	106	28
Metformin Hcl Er	Metformin Hcl	101	39
Alprazolam	Alprazolam	98	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	27
Carvedilol	Carvedilol	87	25
Januvia	Sitagliptin Phosphate	87	21
Ozempic	Semaglutide	87	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	85	31
Fenofibrate	Fenofibrate,micronized	82	11
Synthroid	Levothyroxine Sodium	78	23
Xarelto	Rivaroxaban	77	15
Prednisone	Prednisone	75	40
Tradjenta	Linagliptin	72	18
Citalopram Hbr	Citalopram Hydrobromide	69	23
Finasteride	Finasteride	68	22
Mounjaro	Tirzepatide	63	11
Rosuvastatin Calcium	Rosuvastatin Calcium	63	23
Methylprednisolone	Methylprednisolone	62	46
Ibuprofen	Ibuprofen	59	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	12
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Alendronate Sodium	Alendronate Sodium	51	18
Clonazepam	Clonazepam	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Glipizide	Glipizide	48	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Azithromycin	Azithromycin	46	42
Spironolactone	Spironolactone	46	16
Venlafaxine Hcl Er	Venlafaxine Hcl	45	19
Celecoxib	Celecoxib	44	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	39	11
Ondansetron Odt	Ondansetron	39	16
Temazepam	Temazepam	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	15
Oxybutynin Chloride Er	Oxybutynin Chloride	35	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Valsartan	Valsartan	34	suppressed
Methocarbamol	Methocarbamol	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Metolazone	Metolazone	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	20
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Naproxen	Naproxen	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	18
Sucralfate	Sucralfate	23	11
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Metronidazole	Metronidazole	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Digoxin	Digoxin	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Nystatin	Nystatin	18	suppressed
Unifine Pentips	Pen Needle, Diabetic	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Cimetidine	Cimetidine	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Latanoprost	Latanoprost	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Topiramate	Topiramate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Ibu	Ibuprofen	11	suppressed
Nadolol	Nadolol	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Valproic Acid	Valproic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error